Imunon, Inc. — Director's Dealing 2011

Jul 12, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2011-07-08

Reporting Person: WEAVER GREGORY L (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-07-08	Options to Purchase Celsion Corporation Common Stock	$3.46	A	75000	Acquired	2021-07-08	Celsion Corporation Common Stock (75000)	Direct

Footnotes

F1: The Options vest over four years, with the first vesting date on January 1, 2012, at which date the option grant will be vested 12.5%, and 6.25% will vest each quarter thereafter.

F2: Closing price of Celsion Corporation Common Stock on date of award.